91179-12-3 Usage
Uses
Used in Pharmaceutical Research:
2,5-Dimethyl-4-methoxybenzenesulfonylchloride is used as a reagent in pharmaceutical research for its ability to facilitate a wide range of chemical reactions. Its high reactivity and selective functional group transformations make it a valuable tool in the synthesis of various pharmaceuticals.
Used in Agrochemical Production:
2,5-Dimethyl-4-methoxybenzenesulfonylchloride is used as a reagent in the production of agrochemicals due to its ability to undergo selective and efficient functional group transformations. This allows for the synthesis of a variety of agrochemicals with desired properties.
Used in Medicinal Chemistry:
2,5-Dimethyl-4-methoxybenzenesulfonylchloride is used as a reagent in medicinal chemistry for the synthesis of biologically active compounds. Its high reactivity and ability to undergo a wide range of chemical reactions make it a useful tool in the development of new medicinal compounds.
Used in Organic Synthesis:
2,5-Dimethyl-4-methoxybenzenesulfonylchloride is used as a reagent in organic synthesis for its ability to facilitate a wide range of chemical reactions. Its high reactivity and selective functional group transformations make it a valuable tool in the production of diverse organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 91179-12-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,1,7 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 91179-12:
(7*9)+(6*1)+(5*1)+(4*7)+(3*9)+(2*1)+(1*2)=133
133 % 10 = 3
So 91179-12-3 is a valid CAS Registry Number.
91179-12-3Relevant academic research and scientific papers
Substituted Disulfonamide Compounds
-
Page/Page column 50, (2010/06/22)
Substituted disulfonamide compounds corresponding to formula I: In which R1, R2, R3, R4a, R4b, R5a, R5b, R8, R9a, R9b, R10, R11, a, b, s, t and A have defined meanings, pharmaceutical compositions containing one or more such compounds, processes for preparing such compounds, and a method of using such compounds for the treatment or inhibition of pain and/or other conditions mediated by the bradykinin receptor 1 (BR1).
